Trizna W - Search Results

1

Synthesis and SAR of amino acid-derived heterocyclic progesterone receptor full and partial agonists.

Hammond M, Patterson JR, Manns S, Hoang TH, Washburn DG, Trizna W, Glace L, Grygielko ET, Nagilla R, Nord M, Fries HE, Minick DJ, Laping NJ, Bray JD, Thompson SK. Hammond M, et al. Among authors: trizna w. Bioorg Med Chem Lett. 2009 May 15;19(10):2637-41. doi: 10.1016/j.bmcl.2009.03.146. Epub 2009 Apr 5. Bioorg Med Chem Lett. 2009. PMID: 19376703

2

Design and synthesis of orally bioavailable serum and glucocorticoid-regulated kinase 1 (SGK1) inhibitors.

Hammond M, Washburn DG, Hoang HT, Manns S, Frazee JS, Nakamura H, Patterson JR, Trizna W, Wu C, Azzarano LM, Nagilla R, Nord M, Trejo R, Head MS, Zhao B, Smallwood AM, Hightower K, Laping NJ, Schnackenberg CG, Thompson SK. Hammond M, et al. Among authors: trizna w. Bioorg Med Chem Lett. 2009 Aug 1;19(15):4441-5. doi: 10.1016/j.bmcl.2009.05.051. Epub 2009 May 18. Bioorg Med Chem Lett. 2009. PMID: 19497745

3

Rational design of orally-active, pyrrolidine-based progesterone receptor partial agonists.

Thompson SK, Washburn DG, Frazee JS, Madauss KP, Hoang TH, Lapinski L, Grygielko ET, Glace LE, Trizna W, Williams SP, Duraiswami C, Bray JD, Laping NJ. Thompson SK, et al. Among authors: trizna w. Bioorg Med Chem Lett. 2009 Aug 15;19(16):4777-80. doi: 10.1016/j.bmcl.2009.06.055. Epub 2009 Jun 17. Bioorg Med Chem Lett. 2009. PMID: 19595590

4

Discovery of orally active, pyrrolidinone-based progesterone receptor partial agonists.

Washburn DG, Hoang TH, Frazee JS, Johnson L, Hammond M, Manns S, Madauss KP, Williams SP, Duraiswami C, Tran TB, Stewart EL, Grygielko ET, Glace LE, Trizna W, Nagilla R, Bray JD, Thompson SK. Washburn DG, et al. Among authors: trizna w. Bioorg Med Chem Lett. 2009 Aug 15;19(16):4664-8. doi: 10.1016/j.bmcl.2009.06.081. Epub 2009 Jun 25. Bioorg Med Chem Lett. 2009. PMID: 19616429

5

Development of a small-molecule serum- and glucocorticoid-regulated kinase-1 antagonist and its evaluation as a prostate cancer therapeutic.

Sherk AB, Frigo DE, Schnackenberg CG, Bray JD, Laping NJ, Trizna W, Hammond M, Patterson JR, Thompson SK, Kazmin D, Norris JD, McDonnell DP. Sherk AB, et al. Among authors: trizna w. Cancer Res. 2008 Sep 15;68(18):7475-83. doi: 10.1158/0008-5472.CAN-08-1047. Cancer Res. 2008. PMID: 18794135 Free PMC article.

6

[125I]endothelin-1 binding to renal brush border and basolateral membranes.

Edwards RM, Trizna W, Stack EJ. Edwards RM, et al. Among authors: trizna w. Eur J Pharmacol. 1998 Mar 19;345(2):229-32. doi: 10.1016/s0014-2999(98)00090-9. Eur J Pharmacol. 1998. PMID: 9600642

7

SB 203220: a novel angiotensin II receptor antagonist and renoprotective agent.

Brooks DP, Contino LC, Short BG, Gowan C, Trizna W, Edwards RM. Brooks DP, et al. Among authors: trizna w. J Pharmacol Exp Ther. 1995 Sep;274(3):1222-7. J Pharmacol Exp Ther. 1995. PMID: 7562492

8

alpha-Ketoglutarate transport in rat renal brush-border and basolateral membrane vesicles.

Edwards RM, Stack E, Trizna W. Edwards RM, et al. Among authors: trizna w. J Pharmacol Exp Ther. 1997 Jun;281(3):1059-64. J Pharmacol Exp Ther. 1997. PMID: 9190836

9

Interaction of L-arginine analogs with L-arginine uptake in rat renal brush border membrane vesicles.

Edwards RM, Stack EJ, Trizna W. Edwards RM, et al. Among authors: trizna w. J Pharmacol Exp Ther. 1998 Jun;285(3):1019-22. J Pharmacol Exp Ther. 1998. PMID: 9618403

10

Interaction of nonpeptide angiotensin II receptor antagonists with the urate transporter in rat renal brush-border membranes.

Edwards RM, Trizna W, Stack EJ, Weinstock J. Edwards RM, et al. Among authors: trizna w. J Pharmacol Exp Ther. 1996 Jan;276(1):125-9. J Pharmacol Exp Ther. 1996. PMID: 8558420

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page